In this sense, we observed an increase in plasma cholesterol levels which are linked to the reduced expression of PPARA, and we observed significant differences in its expression in patients with hypercholesterolemia compared to those patients who do not present this comorbidity. This evidence concerns the gene PPARA and Hypercholesterolemia.